Science & Enterprise subscription

Follow us on Twitter

  • Ooops ... https://t.co/G7nkwRtOS8
    about 5 hours ago
  • An international health coalition is funding development of vaccines against the new coronavirus outbreak spreading… https://t.co/6qO4xiglnc
    about 11 hours ago
  • New post on Science and Enterprise: Int’l Group Funding Coronavirus Vaccines https://t.co/lfGeJgppxy #Science #Business
    about 11 hours ago
  • A bio-compatible conduit is shown in tests with monkeys to promote regrowth of damaged nerve fibers, like those suf… https://t.co/Gqt6JkCEil
    about 15 hours ago
  • New post on Science and Enterprise: Implanted Guide Helps Regrow Damaged Body Nerves https://t.co/hlmKUMfNBI #Science #Business
    about 15 hours ago

Please share Science & Enterprise

Infographic – Mediocre ClinicalTrials.gov Report Rates

Chart: Clinical trials report

New data show most sponsors of clinical trials are not reporting their results on time to a U.S. government web site as required by law. . . . → Read More: Infographic – Mediocre ClinicalTrials.gov Report Rates

Vaccine Developer Gains $11M in Early Funds

Baby with microcephaly

A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds

Guidelines Proposed for Complex Clinical Trials

Chemotherapy vials

A working group published guidelines for conducting clinical trials that simultaneously test multiple cancer treatments and can change course over time. . . . → Read More: Guidelines Proposed for Complex Clinical Trials

Commentary – New Models Needed for Antibiotic Resistance

MRSA bacteria

Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge. . . . → Read More: Commentary – New Models Needed for Antibiotic Resistance

Climate Action Cost Accounting Standard Proposed

Climate change skyline

A new paper proposes an accounting standard that would require private companies to spell out their costs of meeting net-zero greenhouse gas emissions. . . . → Read More: Climate Action Cost Accounting Standard Proposed

FDA Blocks Monthly HIV Drug Combo

T-cell infected by HIV

The U.S. Food and Drug Administration rejected a combination of experimental and existing drugs given once a month to treat HIV. . . . → Read More: FDA Blocks Monthly HIV Drug Combo

Psychedelic Depression Drug Tested for Safety

Psilocybe aztecorum

Results from an early clinical trial testing an hallucinogenic drug to treat depression shows the therapy is largely safe and feasible to administer. . . . → Read More: Psychedelic Depression Drug Tested for Safety

Semiconductors Developed to Emulate Nerve Cells

Solid state neuron

Physicists and neuroscientists created semiconductors that in lab simulations and tests with animal models perform like nerve cells for biological functions. . . . → Read More: Semiconductors Developed to Emulate Nerve Cells

Medical Knowledge A.I. Company Raises Early $4.8M

Synthetic biology

A company developing a system with artificial intelligence to analyze medical literature for treatment insights is raising nearly $5 million in its first venture round. . . . → Read More: Medical Knowledge A.I. Company Raises Early $4.8M

Consortium to Advance A.I. in Longevity Research

Hands of older person

A group of academic, foundation, and business organizations are collaborating on the use of artificial intelligence in research on extending life spans. . . . → Read More: Consortium to Advance A.I. in Longevity Research